We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+13.08%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.37B
AUM Growth
+$131M
Cap. Flow
-$20.9M
Cap. Flow %
-1.53%
Top 10 Hldgs %
25.94%
Holding
128
New
8
Increased
15
Reduced
34
Closed
9

Top Buys

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$19.9M
2
CAG icon
Conagra Brands
CAG
+$19.5M
3
NXPI icon
NXP Semiconductors
NXPI
+$19.1M
4
MDT icon
Medtronic
MDT
+$19.1M
5
CVS icon
CVS Health
CVS
+$15.9M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$24.6M
2
AM
ANTERO MIDSTREAM PARTNERS LP
AM
+$17.8M
3
GILD icon
Gilead Sciences
GILD
+$16.6M
4
LVS icon
Las Vegas Sands
LVS
+$15.3M
5
BA icon
Boeing
BA
+$13.5M

Sector Composition

Rank Sector Weight
1 Energy 15.58%
2 Technology 12.95%
3 Financials 12.51%
4 Healthcare 12.33%
5 Consumer Staples 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
T icon
51
AT&T
T
$165B
$14.3M 1.04%
603,082
+582,163
+2,783% +$13.4M
CVS icon
52
CVS Health
CVS
$137B
$13.9M 1.01%
+257,000
New +$15.9M
VLO icon
53
Valero Energy
VLO
$89.8B
$13.9M 1.01%
163,300
MXIM
54
DELISTED
Maxim Integrated Products
MXIM
$13.8M 1.01%
260,100
-136,000
-34% -$7.31M
DD icon
55
DuPont de Nemours
DD
$18.6B
$13.2M 0.97%
98,049
+31,314
+47% +$4.35M
SPG icon
56
Simon Property Group
SPG
$74.5B
$12.9M 0.94%
+70,900
New +$12.6M
MET icon
57
MetLife
MET
$61B
$12.9M 0.94%
303,000
MO icon
58
Altria Group
MO
$122B
$12.7M 0.92%
220,284
BA icon
59
Boeing
BA
$165B
$12.6M 0.92%
33,000
-35,100
-52% -$13.5M
TD icon
60
Toronto Dominion Bank
TD
$198B
$12.5M 0.92%
230,800
-194,300
-46% -$10.7M
BMO icon
61
Bank of Montreal
BMO
$125B
$11.3M 0.83%
151,500
AGG icon
62
iShares Core US Aggregate Bond ETF
AGG
$138B
$7.54M 0.55%
+69,120
New +$7.41M
LQD icon
63
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
$3.18M 0.23%
26,700
AMGN icon
64
Amgen
AMGN
$203B
$2.53M 0.18%
13,330
-128,600
-91% -$24.6M
EMB icon
65
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$1.9M 0.14%
17,300
IBM icon
66
IBM
IBM
$202B
$1.65M 0.12%
12,196
-2,302
-16% -$293K
GILD icon
67
Gilead Sciences
GILD
$161B
$1.48M 0.11%
22,800
-250,200
-92% -$16.6M
IJH icon
68
iShares Core S&P Mid-Cap ETF
IJH
$123B
$1.34M 0.1%
35,325
+13,370
+61% +$494K
TFC icon
69
Truist Financial
TFC
$63.2B
$1.07M 0.08%
22,900
-230,100
-91% -$11.2M
LVS icon
70
Las Vegas Sands
LVS
$30.5B
$933K 0.07%
15,300
-259,500
-94% -$15.3M
EMR icon
71
Emerson Electric
EMR
$82.9B
$924K 0.07%
13,500
-166,600
-93% -$11M
UPS icon
72
United Parcel Service
UPS
$97.6B
$860K 0.06%
7,700
-111,900
-94% -$11.9M
ABBV icon
73
AbbVie
ABBV
$458B
$822K 0.06%
10,200
-128,300
-93% -$10.5M
COR
74
DELISTED
Coresite Realty Corporation
COR
$727K 0.05%
6,790
STI
75
DELISTED
SunTrust Banks, Inc.
STI
$723K 0.05%
12,200
-209,300
-94% -$12.8M

Similar funds

Payden & Rygel's Q1 2019 Portfolio in Review

As of Q1 2019, Payden & Rygel held 128 positions worth $1.37B, up 11% from $1.24B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Payden & Rygel's Q1 2019 filing shows 8 new, 15 increased, 34 reduced and 9 closed positions. Its largest new stake was Williams Companies: 741,800 shares worth $21.3M. The largest sale was Amgen, an estimated $24.6M.

By sector, the portfolio is most concentrated in Energy at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • Payden & Rygel's largest Q1 2019 buy was Williams Companies: 741,800 shares worth $21.3M.
  • Payden & Rygel added most to AT&T in Q1 2019, an estimated $13.4M increase.
  • Payden & Rygel's biggest Q1 2019 reduction was Amgen, cutting an estimated $24.6M.
  • Payden & Rygel fully exited ANTERO MIDSTREAM PARTNERS LP in Q1 2019, selling an estimated $17.8M.
  • Payden & Rygel's ten largest holdings make up 26% of its $1.37B portfolio in Q1 2019.
  • Payden & Rygel opened 8 new positions and closed 9 in Q1 2019.
  • Payden & Rygel's portfolio value rose 11% quarter-over-quarter to $1.37B.

Based on Payden & Rygel's 13F filing for Q1 2019, filed 8 May 2019.